Skip to content
healthcare.dev

Cetirizine Hydrochloride

NDC 81469-353, Cetirizine Hydrochloride, tablet, from First Nation Group, LLC.

Product NDC
81469-353
Status
Listed
Labeler
First Nation Group, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA076047
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81469-353 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
81469-353-0181469035301100 TABLET in 1 BOTTLE (81469-353-01)
81469-353-0381469035303300 TABLET in 1 BOTTLE (81469-353-03)
81469-353-0581469035305500 TABLET in 1 BOTTLE (81469-353-05)
81469-353-908146903539090 TABLET in 1 BOTTLE (81469-353-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 81469-353 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81469-353 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81469-353. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.